The t(8;9)(p22;p24) Is a Recurrent Abnormality in Chronic and Acute Leukemia that Fuses PCM1 to JAK2-Reference-Cited by-同舟云学术

The t(8;9)(p22;p24) Is a Recurrent Abnormality in Chronic and Acute Leukemia that Fuses PCM1 to JAK2

Published:2005-04-01 Issue:7 Volume:65 Page:2662-2667
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Reiter Andreas,Walz Christoph,Watmore Ann,Schoch Claudia,Blau Ilona,Schlegelberger Brigitte,Berger Ute,Telford Nick,Aruliah Shilani,Yin John A.,Vanstraelen Danny,Barker Helen F.,Taylor Peter C.,O'Driscoll Aisling,Benedetti Fabio,Rudolph Cornelia,Kolb Hans-Jochem,Hochhaus Andreas,Hehlmann Rüdiger,Chase Andrew,Cross Nicholas C.P.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 241 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TLE3 Is a Novel Fusion Partner of JAK2 in Myeloid/Lymphoid Neoplasm With Eosinophilia Responding to JAK2 Inhibition;Genes, Chromosomes and Cancer;2024-08

2. Repurposing FDA-approved compounds to target JAK2 for colon cancer treatment;Discover Oncology;2024-06-13

3. Eosinophilia and the Hypereosinophilic Syndrome: Clinical, Molecular and Translational Aspects;Comprehensive Hematology and Stem Cell Research;2024

4. Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase fusion genes: A workshop report with focus on novel entities and a literature review including paediatric cases;Histopathology;2023-08-08

5. Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort;Leukemia;2023-07-15